Ibrutinib for relapsed refractory hairy cell leukemia variant

  • Jan-Paul Bohn, David Wanner, Michael Steurer
  • Leukemia & Lymphoma, October 2016, Taylor & Francis
  • DOI: 10.1080/10428194.2016.1239262

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2016.1239262